Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Stopped The enrollment has been terminated by the NHLBI for administrative reasons.

Conditions

• Heart Failure

Interventions

• BIOLOGICAL: Mesenchymal Precursor cells (RevascorTM)
• DRUG: Cryoprotective media alone

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

• [object Object]
• [object Object]